BLSM ▼ -0.1% - BlossomHill Therapeutics, Inc. $BLSM - BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results BlossomHill Therapeutics reported its second quarter 2026 financial results, with shares down 0.1% on the news. The modest decline suggests investors found the results largely in line with expectations, with no major positive or negative surprises material enough to drive significant movement. 18-SEP-2026 07:00 AM ET